PHRX OTC
Pharmagen, Inc.
1W: +900.0%
1M: +900.0%
3M: +900.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -98.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$692
+0.0% ▲
Capital Expenditures
$57
+0.0% ▲
Free Cash Flow
-$749
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$97
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2013 |
|---|---|
| — Operating Activities — | |
| Net Income | -$6K |
| Depreciation & Amort. | $99 |
| Stock-Based Comp. | $121 |
| Change in Working Capital | $741 |
| Other Non-Cash Items | $4K |
| Operating Cash Flow | -$692 |
| — Investing Activities — | |
| Capital Expenditures | -$57 |
| Acquisitions (Net) | $0 |
| Investment Purchases | $0 |
| Investment Sales | $0 |
| Other Investing | $0 |
| Investing Cash Flow | -$57 |
| — Financing Activities — | |
| Net Debt Issuance | $563 |
| Stock Repurchased | $0 |
| Dividends Paid | $0 |
| Other Financing | $527K |
| Financing Cash Flow | $652 |
| Net Change in Cash | -$97 |
| Cash End of Period | $226 |
| Free Cash Flow | -$749 |